Trial Watch: Phase II and Phase III attrition rates 2011-2012.Published in:Nature Reviews Drug Discovery, 2013, v. 12, n. 8, p. 569, doi. 10.1038/nrd4090By:Arrowsmith, John;Miller, PhilipPublication type:Article